Latest Articles

Article Type

You have access
Targeting enteropeptidase with reversible covalent inhibitors to achieve metabolic benefits
Weimei Sun, Xuqing Zhang, Maxwell D. Cummings, Kamal Albarazanji, JieJun Wu, Mina Wang, Richard Alexander, Bin Zhu, YueMei Zhang, James Leonard, James Lanter and James Lenhard

Journal of Pharmacology and Experimental Therapeutics October 8, 2020, JPET-AR-2020-000219; DOI: https://doi.org/10.1124/jpet.120.000219
You have access
Minoxidil cannot be used to target lysyl hydroxylases during post‑natal mouse lung development: a cautionary note
Tilman Pfeffer, Ettore Lignelli, Hajime Inoue, Ivana Mižíková, David Emmanuel Surate Solaligue, Heiko Steenbock, Despoina Myti, István Vadász, Susanne Herold, Jürgen Brinckmann, Werner Seeger and Rory Edward Morty

Journal of Pharmacology and Experimental Therapeutics October 5, 2020, JPET-AR-2020-000138; DOI: https://doi.org/10.1124/jpet.120.000138
You have access
THE PHOSPHODIESTERASE INHIBITOR ENSIFENTRINE REDUCES PRODUCTION OF PRO-INFLAMMATORY MEDIATORS IN WELL-DIFFERENTIATED BRONCHIAL EPITHELIAL CELLS BY INHIBITING PDE4.
Mark Turner, Nurlan Dauletbaev, Larry Lands and John W. Hanrahan

Journal of Pharmacology and Experimental Therapeutics October 4, 2020, JPET-AR-2020-000080; DOI: https://doi.org/10.1124/jpet.120.000080
You have access
Time-to-event analysis of paclitaxel-associated peripheral neuropathy in advanced non-small cell lung cancer highlighting key influential treatment/patient factors
Francis W. Ojara, Andrea Henrich, Nicolas Frances, Wilhelm Huisinga, Niklas Hartung, Markus Joerger and Charlotte Kloft

Journal of Pharmacology and Experimental Therapeutics October 2, 2020, JPET-AR-2020-000053; DOI: https://doi.org/10.1124/jpet.120.000053
You have access
Adalimumab immunogenicity is negatively correlated with anti-hinge antibody levels in patients with rheumatoid arthritis
Keito Hoshitsuki, Sanjay Rathod, Manda J. Ramsey, Lei Zhu, Larry W. Moreland and Christian A. Fernandez

Journal of Pharmacology and Experimental Therapeutics October 2, 2020, JPET-AR-2020-000179; DOI: https://doi.org/10.1124/jpet.120.000179
You have access
Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19
Mahmood Mozaffari

Journal of Pharmacology and Experimental Therapeutics October 2, 2020, JPET-MR-2020-000243; DOI: https://doi.org/10.1124/jpet.120.000243
You have access
Correction to “Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Epigenetic Regulator Enhancer of Zeste Homolog 2”
Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 238; DOI: https://doi.org/10.1124/jpet.119.263491err
You have access
Interaction of halogenated tyrosine/phenylalanine-derivatives with Organic Anion Transporter (OAT) 1 in the renal handling of tumor imaging probes
Chunhuan Jin, Ling Wei, Ryuichi Ohgaki, Hideyuki Tominaga, Minhui Xu, Suguru Okuda, Hiroki Okanishi, Yasuharu Kawamoto, Xin He, Shushi Nagamori and Yoshikatsu Kanai

Journal of Pharmacology and Experimental Therapeutics September 27, 2020, JPET-AR-2020-000235; DOI: https://doi.org/10.1124/jpet.120.000235
You have access
Activation of naturally occurring LCAT mutants by a novel activator compound
Chiara Pavanello, Alice Ossoli, Marta Turri, Arianna Strazzella, Sara Simonelli, Tommaso Laurenzi, Keita Kono, Keisuke Yamada, Naoki Kiyosawa, Ivano Eberini and Laura Calabresi

Journal of Pharmacology and Experimental Therapeutics September 26, 2020, JPET-AR-2020-000159; DOI: https://doi.org/10.1124/jpet.120.000159
You have access
Monoclonal antibodies counteract opioid-induced behavioral and toxic effects in mice and rats
Carly Anne Baehr, April Huseby Kelcher, Aaron Khaimraj, Dana E Reed, Sujata G Pandit, David AuCoin, Saadyah Averick and Marco Pravetoni

Journal of Pharmacology and Experimental Therapeutics September 26, 2020, JPET-AR-2020-000124; DOI: https://doi.org/10.1124/jpet.120.000124

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals